Pharma The founder and CEO of OAKS Consulting Czech Republic reviews his success story, starting with the change in pricing and reimbursement legislation in 2007, and explains what is needed to gain market access today. Furthermore, he describes the Czech regulatory system as transparent, predictable, and fair—if managed correctly. You founded…
Health The director of the Institute of Health Information and Statistics in the Czech Republic explains his mandate to implement a national health information system and reviews its potential impact. He also identifies how his work will help solve the challenges in the current healthcare system and bring quality healthcare to patients.…
Pharma Eisai’s Czech Republic’s Operations Manager discusses the role Eisai plays in the country, the transparency of the pharma industry in the region, and his aspirations for the future. What does the Czech market have to offer Eisai compared to its neighboring countries? The Czech Republic is one of the most…
Pharma The Country Head Commercial Business of Cipla Czech Republic reviews the challenges faced since Cipla began Czech operations two years ago, the company’s expertise in the respiratory segment, and how high quality products have led to rapid success. You have worked in pharma all of your life including for AstraZeneca,…
Pharma The country manager of Pfizer Czech Republic reviews the advantages of Pfizer’s highly differentiated pipeline and points out how it will impact the success of the Czech affiliate in the future. Furthermore, he describes how he plans to position Pfizer as partner to the relevant stakeholders in order to utilize…
Pharma The Director of the State Institute for Drug Control in the Czech Republic highlights the Czech pharmaceutical industry as emancipated and points out their tremendous contribution to employment, export balance, the economy at large and to the patients. You assumed the position as interim director of the State Institute for…
Pharma The GM of Omega Pharma Czech Republic & Slovakia reveals why the company has to position itself as reliable partner rather than a mere supplier and reviews the 32 percent growth in net sales in 2015, highlighting the significance of market segmentation, re-focusing on core assets, and the role of…
Pharma The Czech Minister of Health reviews his achievements in his first two years as minister and elaborates on the National Strategy “Health 2020” implemented in early 2014. He furthermore comments on the financial situation of the Czech health system and names spending as percentage of GDP in comparison to the OECD…
Pharma The country president of Novartis Czech Republic explains the strategy that led the affiliate to become the number one pharmaceutical company in the Czech market, highlighting the significance of her team in accomplishing 8.4 percent market share. Furthermore, she shares news of recent significant investments into clinical trials and a…
Pharma Michaela Hrdlickova of Biogen elaborates on how it is the industry’s responsibility to educate all stakeholders within the Czech Republic in order to embed a health consciousness in every individual and discusses the unique referencing methods applied in the country and their resulting challenges for both industry and patient. When…
Pharma The executive director of the American Chamber of Commerce in the Czech Republic discusses measuring the impact that healthcare policy changes have on the healthy life years of Czechs. Furthermore, he identifies the Czech people as a most important asset which sets the nation apart from its neighbors. The AmCham…
Pharma The CEO of CzechInvest elaborates on the significance of the healthcare and life science industry for the Czech Republic’s transition into an industry 4.0. Furthermore, he reviews what the Czech Republic has to offer for foreign investors over its regional neighbors. Before assuming the position of CEO at CzechInvest you…
See our Cookie Privacy Policy Here
